Decision Resources, Inc., June 2009, Pages: 31
Considerations
Stakeholder Implications
Introduction
Regulatory Structure
Ministry of Health
State Food and Drug Administration
Ministry of Human Resources and Social Security
National Development
Decision Resources, Inc., Oct 2006, Pages: 30
Companion diagnostics will play an increasing role in cancer care. Pharmaceutical companies developing targeted therapies for cancer must consider the potential benefi ts of developing a companion
Elsevier Science and Technology, Nov 2007, Pages: 496
explain the basic underlying principles of cancer drug development and provide a practical introduction to modern methods of drug design. Appealing to a broad audience, this is an excellent reference
iCD Research, Sep 2011, Pages: 50
and suppliers
- Obtain yearly profitability figures
Key Highlights
Schering-Plough Corporation (Schering-Plough) is a pharmaceutical company focused on discovery, development, manufacturing and marketing
Business Review, Nov 2010, Pages: 29
.
- Obtain yearly profitability figures
Key Highlights
Schering-Plough Corporation (Schering-Plough) is a pharmaceutical company focused on discovery, development, manufacturing and marketing of medical
John Wiley and Sons Ltd, Sep 2007, Pages: 312
development and drug discovery with a reference to oncogenomics, proteomics, metabolomics as well as combinatorial chemistry techniques and the discovery of chemotherapeutic agents from plant extracts
GlobalData, June 2011, Pages: 113
on the company’s business segments, major products and services, competitors, locations and subsidiaries, financial deals and other key developments.
This report is built using data and information sourced from
GlobalData, June 2011, Pages: 82
disease markets in the long run.
Reasons to buy
The report will serve to facilitate your decision making in the concerned therapy areas. It will allow you to -
- Develop business strategies
